Fri, Apr 05, 2024
Cipla on Thursday said that a routine current Good Manufacturing Practices (cGMP) inspection was conducted by the United States Food and Drug Administration (USFDA) at the manufacturing facility of the company located in Patalganga, Maharashtra, India from March 28, 2024, to April 4, 2024.
More >
Mon, Mar 11, 2024
Cipla share price: Cipla's stock was trading up by 2.11 per cent, or Rs 31.30, at Rs 1513.25 at 10:43 am on Monday. The stock that closed at Rs 1481.95 on Friday started its trading session on Monday at Rs 1490.35.
Mon, Jan 29, 2024
Shares of Cipla dipped 3% as Samina Hamied resigned as executive vice-chair, transitioning to a non-executive director role. The move is part of a broader strategy to professionalize Cipla's management, akin to conglomerates like the Tata Group. Balram Bhargava was appointed as an additional independent director, bringing over 35 years of global public health leadership experience.
Thu, Sep 14, 2023
Cipla से जुड़ी Big news related to Cipla: Bids to buy promoters' shares will start soon, bids to buy shares possible by the third week of this month.
Mon, Aug 21, 2023
Big news for Cipla and TorrentPharma! Can Cipla promoters sell stake? Know full details in this video
Tue, Apr 18, 2023
Top Gainers & Losers: Reversing its early gains, BSE Sensex fell 183.74 points or 0.31 per cent to settle at 59,727.01.
Wed, Jan 11, 2023
Jefferies and HSBC have recommended, Cipla, Sun Pharma, Divi's Laboratories, Biocon, Lupin and others
Wed, May 11, 2022
Cipla Share Price:Brokerages are bullish on the Cipla shares and expects a 28 per cent upside in this stock. A healthy March quarter results will likely act as a trigger for the upside, they opined.
Thu, Jan 27, 2022
Brokerage house ICICI Securities and HDFC securities have maintained buy rating on Cipla despite the pharma major witnessed marginal decline in net profit.
Wed, Oct 27, 2021
We have collated a list of recommendations covered on Zee Business TV from top global brokerage firms on stocks like Cipla, Ambuja Cement, IRB Infrastructure & Axis Bank that came out with results on Tuesday.
Mon, Dec 14, 2020
Cipla is licensed to sell volume-limited quantity after Mar 2022 and without volume-restriction after Jan 31, 2026 subject to product approval from the US FDA. While the details pertaining to launch date and market share are not disclosed, the opportunity can add an NPV of Rs4 0/share to target price in a base case scenario (assuming 5-10% market share, 30-50% price erosion between FY23-26). HDFC Securities increased their target price to Rs 940 to factor gRevlimid launch in FY23 and maintained BUY rating. Key catalysts are ramp-up in Albuterol, progress on IV Tramadol, limited competition launches in the US.
Fri, Aug 19, 2016
Last week, the company reported a 43.74% drop in consolidated net profit at Rs 365.24 crore for the quarter ended on June 30, 2016.
Fri, Aug 12, 2016
Shares of State Bank of India, Sun Pharmaceuticals and Cipla will be in focus today as the companies are set to announce financial results for the quarter ended on June 30.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.